#ACC22 – Estudo randomizado | Entre pacientes ambulatoriais com insuficiência cardíaca, uma intervenção dietética para reduzir a ingestão de sódio não reduziu os eventos clínicos.
5 Abr, 2022 | 12:23hReduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial – The Lancet (necessário cadastro gratuito)
Comentários:
SODIUM-HF: No Impact of Dietary Salt Restriction on Death or Hospitalization – TCTMD
Comentário no Twitter
Nutritional counseling/strictly limiting sodium intake didn’t significantly reduce MACE in #HeartFailure patients in 6️⃣ countries, but did modestly improve QOL according to results of SODIUM-HF trial presented at #ACC22. https://t.co/ESjiy6g8a7 #ACCIntl #cvPrev #CardioNutrition pic.twitter.com/CjK6CfWNXg
— American College of Cardiology (@ACCinTouch) April 2, 2022